Exelixis
EXEL
#1683
Rank
C$14.11 B
Marketcap
$49.44
Share price
1.51%
Change (1 day)
70.05%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company